市場調査レポート

トランスフェクション技術の世界市場(試薬法、器具法、ウィルス法) - 産業分析、市場の規模、シェア、成長性、動向および予測

Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 300961
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
トランスフェクション技術の世界市場(試薬法、器具法、ウィルス法) - 産業分析、市場の規模、シェア、成長性、動向および予測 Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年04月24日 ページ情報: 英文 120 Pages
概要

当レポートでは、トランスフェクション技術(遺伝子・ウイルスなどの核酸を細胞に取り込んで増殖させる技術)の世界市場に注目し、2013-2019年の期間におけるその推移を技術方式、用途および地域の別に予測するほか、市場全体の動向、技術開発、推進・抑制要因、機会、競合環境などの分析情報に主要参入企業のプロフィールを加え、概略以下の構成でお届けします。

第1章 はじめに

  • レポート内容
  • 市場セグメンテーション
  • 調査方法
  • 略語一覧

第2章 エグゼクティブサマリー

  • 市場寸見:トランスフェクション技術の世界市場
    • トランスフェクション技術の世界市場 - 方式別:2012年(単位:100万米ドル)
  • 比較分析:トランスフェクション技術の世界市場 - 地域別(価額比)

第3章 市場概要

  • イントロダクション
  • 市場の定義と概要
  • 市場動態
    • 推進要因
      • タンパク質生産がトランスフェクション技術の利用を促進
      • トランスフェクションの需要拡大を大幅に推進するアジアの新興生物医薬品市場
    • 抑制要因
      • 高コストが十分な市場拡大の障害に
    • 機会
      • 幹細胞研究に向けたトランスフェクション技術
  • Porterのファイブフォース分析:トランスフェクション技術の世界市場
  • 市場求心力分析
  • 競合環境

第4章 トランスフェクション技術の世界市場 - 技術方式別

  • 概要
    • トランスフェクション技術の世界市場収益 - 技術方式別(単位:100万米ドル)
  • 試薬法
    • 試薬法の世界市場収益 - 試薬種別(単位:100万米ドル)
    • 脂質仲介トランスフェクション(Lipofection)
    • リン酸カルシウム
    • カチオン性ポリマー
    • ジエチルアミノエチルデキストラン
    • 活性化デンドリマー
    • 電磁ビーズ
  • 器具法
    • 器具法の世界市場収益 - 器具種別(単位:100万米ドル)
    • 電気穿孔法
    • 微粒子銃技術
    • マイクロインジェクション
    • レーザーフェクション
  • ウィルス法
    • ウィルス法の世界市場収益(単位:100万米ドル)

第5章 トランスフェクション技術の世界市場 - 用途別

  • 概要
    • トランスフェクション技術の世界市場収益 - 用途別(単位:100万米ドル)
  • 生物医学研究
    • 生物医学研究の世界市場収益 - 研究対象別(単位:100万米ドル)
    • 遺伝子組み換えモデル
    • がん研究
    • 遺伝子およびタンパク質発現研究
    • 創薬・薬剤開発用細胞ベースマイクロアレイ
  • 治療薬送達
    • 治療薬送達の世界市場収益 - 療法別(単位:100万米ドル)
    • 生物療法
    • 電気化学療法
  • タンパク質生産
    • タンパク質生産の世界市場収益(単位:100万米ドル)

第6章 トランスフェクション技術の世界市場 - 地域別

  • 概要
    • トランスフェクション技術の世界市場収益 - 地域別(単位:100万米ドル)
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第7章 提言

  • 成功への市場戦略
    • 新技術の開発と製品の改善
    • 幹細胞研究トランスフェクションに向けた製品ポートフォリオの強化
  • 障害と想定される未来
    • 高コストが十分な市場拡大への障害に

第8章 企業プロフィール(企業概要、財務概要、製品ポートフォリオ、事業戦略、最新展開)

  • Bio-Rad Laboratories, Inc.
  • Harvard Bioscience, Inc.
  • Life Technologies Corporation
  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • Polyplus-transfection S.A.
  • Promega Corporation
  • QIAGEN
  • Roche Holding AG
  • Sigma-Aldrich Corporation
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.
目次

Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The transfection technology market is driven by factors such as increasing demand for protein production, emerging biopharmaceutical market and rising prevalence of cancer and infectious diseases, globally.

The report explains various advancements taking place in this market and analyses the global transfection technology market by types of methods and applications. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method.

The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.The transfection technology market has also been segmented on the basis of its application in biomedical research, therapeutic delivery (biotherapeutics and electro-chemotherapy and electro-immunotherapy) and protein production. Furthermore, the biomedical research segment includes transgenic models, cancer research, gene and protein expression studies and cell-based microarrays for drug discovery and development.

The report includes estimations of the global transfection technology market in terms of its value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global transfection technology market. The report provides market size and forecasts for each segment, sub-segment and geographic region with CAGR % for the period 2013 - 2019.

Geographically, transfection technology market has been segmented into four regions which include North America, Europe, Asia-Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the transfection technology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for the existing as well as the new entrants has also been discussed in the study that is expected to help in decision-making.

Some of the major players profiled in the transfection technology market report include companies such as Sigma Aldrich Corporation, SignaGen Laboratories, Lonza Group Ltd., Life Technologies, Bio-Rad Laboratories Inc., Promega Corporation and QIAGEN. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The transfection technologymarket is segmented into the following categories:

Transfection Technology Market, by Methods

  • Reagent-based Method
  • Lipid mediated transfection (Lipofection)
  • Calcium phosphate
  • Catonic polymers
  • DEAE-dextran
  • Activated dendrimers
  • Magnetic beads
  • Instrument-based Method
  • Electroporation
  • Biolistic technology
  • Microinjection
  • Laserfection
  • Virus-based Method

Transfection Technology Market, by Applications

  • Bio-medical Research
    • Transgenic models
    • Cancer Research
    • Gene and protein expression studies
    • Cell based microarrays for drug discovery and development
  • Therapeutic Delivery
    • Biotherapeutics
    • Electro-chemotherapy and electro-immunotherapy
  • Protein Production

Transfection Technology Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of The Worl

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
    • 2.1.1 Global Transfection Technology Market, by Methods, 2012 (USD Million)
  • 2.2 Comparative Analysis: Global Transfection Technology Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview

  • 3.1 Market Definition and Overview
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
      • 3.2.1.1 Protein production promotes the use of transfection technology methods
      • 3.2.1.2 Emerging biopharmaceutical markets in Asia boost transfection needs
    • 3.2.2 Restraints
      • 3.2.2.1 High cost prevents sufficient market expansion
    • 3.2.3 Opportunities
      • 3.2.3.1 Transfection technologies for stem cell research
  • 3.3 Porters Five Force Analysis for the Global Transfection Technology Market
    • 3.3.1 Bargaining Power of Suppliers
    • 3.3.2 Bargaining Power of Buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Competitive Rivalry
  • 3.4 Market Attractiveness Analysis
  • 3.5 Competitive Landscape
    • 3.5.1 Market Share Analysis by Key Players, 2012 (Value %)

Chapter 4 Global Transfection Technology Market, by Methods

  • 4.1 Overview
    • 4.1.1 Global Transfection Technology Market Revenue, by Methods, 2011 - 2019 (USD Million)
  • 4.2 Reagent-based Methods
    • 4.2.1 Global Reagent Based Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.2.2 Lipid Mediated Transfection (Lipofection)
      • 4.2.2.1 Global Lipid Mediated Transfection Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.3 Calcium Phosphate
      • 4.2.3.1 Global Calcium Phosphate Transfection Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.4 Cationic Polymers
      • 4.2.4.1 Global Cationic Polymer Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.5 DEAE dextran
      • 4.2.5.1 Global DEAE-dextran Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.6 Activated Dendrimers
      • 4.2.6.1 Global Activated Dendrimers Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.7 Magnetic Beads (Magnet-mediated transfection)
      • 4.2.7.1 Global Magnetic Beads Transfection Market Revenue, 2011 - 2019 (USD Million)
  • 4.3 Instrument-based Methods
    • 4.3.1 Global Instrument Based Method Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.3.2 Electroporation
      • 4.3.2.1 Global Electroporation Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.3 Biolistic Technology
      • 4.3.3.1 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.4 Microinjection
      • 4.3.4.1 Global Microinjection Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.5 Laserfection
      • 4.3.5.1 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • 4.4 Virus-based Methods
    • 4.4.1 Global Virus Based Method Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Transfection Technology Market, By Application

  • 5.1 Overview
    • 5.1.1 Global Transfection Technology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2 Bio-medical Research
    • 5.2.1 Global Bio-medical Research Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 5.2.2 Transgenic Models
      • 5.2.2.1 Global Transgenic Model Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.3 Cancer Research
      • 5.2.3.1 Global Cancer Research Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.4 Gene and Protein Expression Studies
      • 5.2.4.1 Global Gene and Protein Expression Studies Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.5 Cell Based Microarray for Drug Discovery and Development
      • 5.2.5.1 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Therapeutic Delivery
    • 5.3.1 Global Therapeutics Delivery Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 5.3.2 Biotherapeutics
      • 5.3.2.1 Global Biotherapeutics Market Revenue, 2011 - 2019 (USD Million)
    • 5.3.3 Electro-chemotherapy and Electro-immunotherapy
      • 5.3.3.1 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • 5.4 Protein Production
    • 5.4.1 Global Protein Production Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Global Transfection Technology Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Transfection Technology Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Transfection Technology Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Develop new technologies and product improvement
    • 7.1.2 Enhance product portfolio for stem cell research transfection
  • 7.2 Barriers and Future Assumptions
    • 7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles

  • 8.1 Bio-Rad Laboratories, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Harvard Bioscience, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Life Technologies Corporation
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 Lonza Group Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Merck KGaA
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Mirus Bio LLC
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Development
  • 8.7 Polyplus-transfection S.A.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Promega Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Strategic Alliance
    • 8.8.6 Recent Developments
  • 8.9 QIAGEN
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
  • 8.10 Roche Holding AG
    • 8.10.1 Company Overview
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Development
  • 8.11 Sigma-Aldrich Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.11.5 Recent Developments
  • 8.12 SignaGen Laboratories
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product Portfolio
    • 8.12.4 Recent Developments
  • 8.13 Thermo Fisher Scientific, Inc.
    • 8.13.1 Company Overview
    • 8.13.2 Financial Overview
    • 8.13.3 Product Portfolio
    • 8.13.4 Business Strategies
    • 8.13.5 Recent Developments

List of Figures

  • FIG. 1 Transfection Technology: Market Segmentation
  • FIG. 2 Global Transfection Technology Market, by Methods, 2012 (USD Million)
  • FIG. 3 Comparative Analysis: Global Transfection Technology Market, by Geography, 2012 and 2019 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Transfection Technology Market
  • FIG. 5 Market Attractiveness Analysis: Global Transfection Technology Market, by Geography
  • FIG. 6 Market Share Analysis: Transfection Technology Market, 2012 (Value %)
  • FIG. 7 Global Lipid Mediated Transfection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 8 Global Calcium Phosphate Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9 Global Cationic Polymer Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10 Global DEAE-dextran Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11 Global Activated Dendrimers Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Magnetic Beads Transfection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Global Magnetic Beads Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 Global Microinjection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Global Virus Based Method Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Global Transgenic Model Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 Global Cancer Research Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Global Gene and Protein Expression Studies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22 Global Biotherapeutics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25 North America Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 26 Europe Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 27 Asia-Pacific Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 28 RoW Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 29 Annual Sales: Bio-Rad Laboratories, Inc., Life Science Segment, 2010 - 2012 (USD Million)
  • FIG. 30 Annual Sales: Harvard Bioscience, Inc., 2010 - 2012 (USD Million)
  • FIG. 31 Annual Sales: Life Technologies Corporation, 2010 - 2012 (USD Million)
  • FIG. 32 Annual Sales: Lonza Group Ltd., Bioscience Segment , 2010 - 2012 (USD Million)
  • FIG. 33 Annual Sales: Merck KGaA, Merck Millipore , 2010 - 2012 (USD Million)
  • FIG. 34 Annual Sales: QIAGEN, 2010 - 2012 (USD Million)
  • FIG. 35 Annual Sales: Roche Holding AG, 2010 - 2012 (USD Million)
  • FIG. 36 Annual Sales: Sigma-Aldrich Corporation, 2010 - 2012 (USD Million)
  • FIG. 37 Annual Sales: Thermo Fisher Scientific, 2010- 2012 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
  • TABLE 3 Global Transfection Technology Market Revenue, by Methods, 2011 - 2019 (USD Million)
  • TABLE 4 Global Reagent Based Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 5 Global Instrument Based Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 6 Global Transfection Technology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • TABLE 7 Global Bio-medical Research Market Revenue, by Types, 2011 - 2019(USD)
  • TABLE 8 Drug Delivery Methods with their Carriers/Factors
  • TABLE 9 Global Therapeutics Delivery Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 10 Global Transfection Technology Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top